Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04116697 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan
A NA study, sponsored by Englewood Hospital and Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04116697 is a NA study that has completed, run by Englewood Hospital and Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT04116697, a NA study, has completed, sponsored by Englewood Hospital and Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The overall goal of this study is to explore the effectiveness of using acupuncture versus aromatherapy, in conjunction with standard of care anti-emetics, to decrease chemotherapy induced nausea, vomiting, and anxiety in breast cancer patients undergoing Adriamycin and Cytoxan. This study also aims to determine if aromatherapy and anti-emetics is more effective than acupuncture and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan and if acupuncture and anti-emetics is more effective than aromatherapy and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan.
Interventions
- OTHER Acupuncture
- OTHER Aromatherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04116697
The ClinicalTrials.gov registry entry for NCT04116697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Englewood Hospital and Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acupuncture is the first listed.
NCT04116697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04116697 about?
NCT04116697 is a clinical study titled "A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan". The overall goal of this study is to explore the effectiveness of using acupuncture versus aromatherapy, in conjunction with standard of care anti-emetics, to decrease chemotherapy induced nausea, vomiting, and anxiety in breast cancer patients undergoing Adriamycin and Cytoxan. This study also aims...
What is the current status of trial NCT04116697?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-10-23. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT04116697?
The interventions under investigation include: Acupuncture (OTHER), Aromatherapy (OTHER).
Who is sponsoring clinical trial NCT04116697?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.